Squalene-PEG: Pyropheophorbide-a nanoconstructs for tumor theranostics.


Journal

Nanomedicine : nanotechnology, biology, and medicine
ISSN: 1549-9642
Titre abrégé: Nanomedicine
Pays: United States
ID NLM: 101233142

Informations de publication

Date de publication:
01 2019
Historique:
received: 20 02 2018
revised: 11 09 2018
accepted: 24 09 2018
pubmed: 12 10 2018
medline: 6 2 2019
entrez: 11 10 2018
Statut: ppublish

Résumé

Novel nanoscale drug delivery biomaterials are of great importance for the diagnosis and treatment of different cancers. We have developed a new pegylated squalene (SQ-PEG) derivative with self-assembly properties. Supramolecular assembly with a lipophilic photosensitizer pyropheophorbide-a (Ppa) by nanoprecipitation gave nanoconstructs SQ-PEG:Ppa with an average size of 200 nm in diameter and a drug loading of 18% (w/w). The composite material demonstrates nanoscale optical properties by tight packing of Ppa within Sq-PEG:Ppa resulting in 99.99% fluorescence self-quenching. The biocompatibility of the nanomaterial and cell phototoxicity under light irradiation were investigated on PC3 prostate tumor cells in vitro. SQ-PEG:Ppa showed excellent phototoxic effect at low light dose of 5.0 J/cm

Identifiants

pubmed: 30304701
pii: S1549-9634(18)30532-X
doi: 10.1016/j.nano.2018.09.013
pii:
doi:

Substances chimiques

Photosensitizing Agents 0
Chlorophyll 1406-65-1
pyropheophorbide a 24533-72-0
Polyethylene Glycols 3WJQ0SDW1A
Squalene 7QWM220FJH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-251

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Souad Adriouach (S)

Pharmaceutical Technology, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva 4, Switzerland.

Vassily Vorobiev (V)

Pharmaceutical Technology, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva 4, Switzerland.

Gregor Trefalt (G)

Laboratory of Colloid and Surface Chemistry, Department of Chemistry, University of Geneva, Geneva 4, Switzerland.

Eric Allémann (E)

Pharmaceutical Technology, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva 4, Switzerland.

Norbert Lange (N)

Pharmaceutical Technology, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva 4, Switzerland.

Andrej Babič (A)

Pharmaceutical Technology, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva 4, Switzerland. Electronic address: andrej.babic@unige.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH